Oncogene Science Incorporated

Contact Details: 106 Charles Lindbergh Boulevard Uniondale NY 11553-3649 United States of America Tel: 516 222 0023 Fax: 516 222 0114 Email: WWW: www.oncogene.com/

Loading...

Recent Publications by Oncogene Science Incorporated:
Hidden HER-2/neu-positive breast cancer: how to maximize detection. The HER-2/neu oncoprotein is an important cellular target for the...	6th August, 2009	Oncogene Science, Siemens Healthcare Diagnostics Inc, 80 Rogers Street,	IDrugs. 2009 Apr;12(4):238-42.
Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers. Pharmaceutical companies have developed targeted therapies such as...	20th January, 2009	Oncogene Science, Siemens Medical Solutions Diagnostics, Cambridge, MA	Expert Rev Mol Diagn. 2007 May;7(3):309-19. DOI Direct Link
HER-2/neu diagnostics in breast cancer. HER-2/neu status of the primary breast cancer (PBC) is determined by...	15th September, 2007	Oncogene Science, Siemens Medical Solutions Diagnostics, Rogers Street,	Breast Cancer Res. 2007;9(3):207. DOI Direct Link
Inhibition of the HIV Rev transactivator : a new target for therapeutic intervention. The viral transactivator Rev is essential for HIV replication, since it...	25th March, 2006	Oncogene Science, Inc., 106 Charles Lindbergh Blvd., Uniondale, NY 11553,	Front Biosci. 1997 Jun 1;2:d283-97.
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer. The HER2/neu oncoprotein is a major target for the development of new...	6th October, 2004	Oncogene Science, Bayer HealthCare, Cambridge, MA 02142, USA.	Clin Breast Cancer. 2004 Jun;5(2):105-16.
→View more Oncogene Science Incorporated research publications.

Press Releases on Oncogene Science Incorporated:
Reportlinker Adds In Vitro Diagnostics US Market Report	1st October, 2009	Reportlinker	NEW YORK, Oct. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. In Vitro Diagnostics US Market http://www.reportlinker.com/p0109780/In

Oncogene Science Incorporated Patents:
US Patent No.	Title
5976793	Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators
5217896	Monoclonal antibodies recognizing parathyroid hormone-like protein
5262319	Method for obtaining bone marrow free of tumor cells using transforming growth factor .beta.3
5262523	Antibodies reactive with normal and oncogenic forms of the ras p21 protein
5401638	Detection and quantification of neu related proteins in the biological fluids of humans
→View more Oncogene Science Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1450 times since April 2007, the link to the organisation's website has been followed 308 times

Recent Search Terms used to find this page: oncogene Science Inc. contact email | oncogene science | oncogene science | oncogene science | oncogene sciences siemens | Oncogene Science | Oncogene Science | oncogene science antibodies | oncogene science | Oncogene science | .

Search for more companies in Uniondale

Search for more companies in NY

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Oncogene Science Incorporated